Intro

This chapter examines the alarming trend of private health insurers denying prescription drug claims, showing a 25% increase in denial rates from 2016 to 2023. It highlights real-world examples, such as issues with asthma inhalers and weight loss medications, illustrating the struggles patients encounter in obtaining necessary treatments.